What is the share price of Starsource Multitrade Ltd (STARSOURCE) today?
The share price of STARSOURCE as on 27th February 2026 is ₹95.50. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Starsource Multitrade Ltd (STARSOURCE) share?
The past returns of Starsource Multitrade Ltd (STARSOURCE) share are- Past 1 week: -4.50%
- Past 1 month: -23.14%
- Past 3 months: -9.05%
- Past 6 months: -15.56%
- Past 1 year: 13.19%
- Past 3 years: 144.87%
- Past 5 years: 342.13%
What are the peers or stocks similar to Starsource Multitrade Ltd (STARSOURCE)?
The peers or stocks similar to Starsource Multitrade Ltd (STARSOURCE) include:What is the market cap of Starsource Multitrade Ltd (STARSOURCE) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Starsource Multitrade Ltd (STARSOURCE) is ₹14.32 Cr as of 27th February 2026.What is the 52 week high and low of Starsource Multitrade Ltd (STARSOURCE) share?
The 52-week high of Starsource Multitrade Ltd (STARSOURCE) is ₹152.90 and the 52-week low is ₹84.37.What is the PE and PB ratio of Starsource Multitrade Ltd (STARSOURCE) stock?
The P/E (price-to-earnings) ratio of Starsource Multitrade Ltd (STARSOURCE) is 43.41. The P/B (price-to-book) ratio is 1.09.Which sector does Starsource Multitrade Ltd (STARSOURCE) belong to?
Starsource Multitrade Ltd (STARSOURCE) belongs to the Communication Services sector & Advertising sub-sector.How to buy Starsource Multitrade Ltd (STARSOURCE) shares?
You can directly buy Starsource Multitrade Ltd (STARSOURCE) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Starsource Multitrade Ltd
STARSOURCE Share Price
BSE₹95.504.95% (+4.50)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
STARSOURCE Stock Scorecard
Performance
AvgPrice return has been average, nothing exciting
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is not in the overbought zone
Red flags
AvgThe stock has a moderate number of red flags
How to use scorecard? Learn more
STARSOURCE Performance & Key Metrics
STARSOURCE Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| -1.18 | 1.09 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 101.62 | 8.20 | 0.81% |
STARSOURCE Analyst Ratings & Forecast
—
Analyst Ratings data is currently unavailable for this stockPrice Upside
Earnings Growth
Rev. Growth
STARSOURCE Company Profile
Starsource Multitrade Limited formerly Chemo Pharma Laboratories Limited has no current operations and is exploring new business opportunities in India.
AFFLE
PE Ratio
50.71
50.71
1Y Return
5.67%
5.67%
Buy Reco %
100.00
100.00
PE Ratio
3.04
3.04
1Y Return
48.29%
48.29%
MOBAVENUE
PE Ratio
2,428.44
2,428.44
1Y Return
100.86%
100.86%
Buy Reco %
0.00
0.00
SIGNPOST
PE Ratio
39.80
39.80
1Y Return
6.99%
6.99%
Buy Reco %
0.00
0.00
PE Ratio
335.93
335.93
1Y Return
8.89%
8.89%
Buy Reco %
0.00
0.00
STARSOURCE Forecast
STARSOURCE Forecasts
Forecast data is currently unavailable
Forecast data is currently unavailable
Price
Price Upside
Revenue
Revenue Growth
Earnings
Earnings Per Share
STARSOURCE
STARSOURCE
Income
Balance Sheet
Cash Flow
Quarterly Normal View
STARSOURCE Income Statement
STARSOURCE Income Statement
Quarterly Normal View
| Quarter | sep 2023 | dec 2023 | mar 2024 | jun 2024 | sep 2024 | dec 2024 | mar 2025 | jun 2025 | sep 2025 | dec 2025 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0.46 | 0.70 | 0.25 | 0.30 | 0.63 | -0.15 | -0.16 | 0.02 | 0.53 | 0.00 | ||||||||||
Operating & Other expenses | 0.02 | 0.02 | 0.09 | 0.05 | 0.02 | 0.02 | 0.02 | 11.83 | 0.43 | 0.09 | ||||||||||
EBITDA | 0.44 | 0.68 | 0.16 | 0.25 | 0.61 | -0.17 | -0.18 | -11.81 | 0.10 | -0.09 | ||||||||||
| Depreciation/Amortization | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||
| PBIT | 0.44 | 0.68 | 0.16 | 0.25 | 0.61 | -0.17 | -0.18 | -11.81 | 0.10 | -0.09 | ||||||||||
| Interest & Other Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||
| PBT | 0.44 | 0.68 | 0.16 | 0.25 | 0.61 | -0.17 | -0.18 | -11.81 | 0.10 | -0.09 | ||||||||||
| Taxes & Other Items | 0.00 | 0.00 | 0.44 | 0.00 | 0.00 | 0.00 | 0.16 | 0.00 | 0.00 | 0.00 | ||||||||||
| Net Income | 0.44 | 0.68 | -0.28 | 0.25 | 0.61 | -0.17 | -0.34 | -11.81 | 0.10 | -0.09 | ||||||||||
| EPS | 2.93 | 4.51 | -1.94 | 1.64 | 4.07 | -1.17 | -2.26 | -78.70 | 0.65 | -0.58 |
STARSOURCE Company Updates
STARSOURCE Stock Peers
STARSOURCE Past Performance & Peer Comparison
STARSOURCE Past Performance & Peer Comparison
Comparing 3 stocks from
Communication ServicesAdvertising
Compare valuation on Screener
Communication ServicesAdvertising
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Starsource Multitrade Ltd | 43.41 | 1.09 | — |
| Affle 3i Ltd | 50.71 | 6.57 | — |
| Brightcom Group Ltd | 3.04 | 0.25 | — |
| Mobavenue Ai Tech Ltd | 2,428.44 | 125.19 | — |
STARSOURCE Stock Price Comparison
Compare STARSOURCE with any stock or ETFCompare STARSOURCE with any stock or ETF
STARSOURCE
STARSOURCE Holdings
STARSOURCE Shareholdings
STARSOURCE Promoter Holdings Trend
STARSOURCE Promoter Holdings Trend
Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
STARSOURCE Institutional Holdings Trend
STARSOURCE Institutional Holdings Trend
Decreased Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has decreased by 1.22%
Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has almost stayed constant
STARSOURCE Shareholding Pattern
STARSOURCE Shareholding Pattern
STARSOURCE Shareholding History
STARSOURCE Shareholding History
Foreign Institutions
Hmm, looks like there hasn't been any net deal activity in the last 6 monthssmallcases containing STARSOURCE stock
smallcases containing STARSOURCE stock
Looks like this stock is not in any smallcase yet.
STARSOURCE Events
STARSOURCE Events
STARSOURCE Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
STARSOURCE has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
STARSOURCE Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
STARSOURCE has not given any dividends in last 5 years
STARSOURCE Dividends
STARSOURCE Dividends
Hmm, looks like data is unavailable here. Please come back after some timeSTARSOURCE Stock News & Opinions
STARSOURCE Stock News & Opinions
Articles & Videos
Earnings
Starsource Multitrade reports standalone net loss of Rs 0.09 crore in the December 2025 quarter
Net Loss of Starsource Multitrade reported to Rs 0.09 crore in the quarter ended December 2025 as against net loss of Rs 0.17 crore during the previous quarter ended December 2024. There were no Sales reported in the quarter ended December 2025 and during the previous quarter ended December 2024.Powered by Capital Market - Live
2 weeks agoCapital Market - Live
Corporate
Starsource Multitrade to conduct board meeting
Starsource Multitrade will hold a meeting of the Board of Directors of the Company on 12 February 2026.Powered by Capital Market - Live
2 weeks agoCapital Market - Live
Earnings
Starsource Multitrade standalone net profit declines 83.61% in the September 2025 quarter
Net profit of Starsource Multitrade declined 83.61% to Rs 0.10 crore in the quarter ended September 2025 as against Rs 0.61 crore during the previous quarter ended September 2024. Sales reported to Rs 0.53 crore in the quarter ended September 2025. There were no Sales reported during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales0.530 0 OPM %18.870 - PBDT0.100.61 -84 PBT0.100.61 -84 NP0.100.61 -84 Powered by Capital Market - Live
3 months agoCapital Market - Live
Corporate
Starsource Multitrade announces board meeting date
Starsource Multitrade will hold a meeting of the Board of Directors of the Company on 13 November 2025.Powered by Capital Market - Live
3 months agoCapital Market - Live
Corporate
Chemo Pharma Laboratories AGM scheduled
Chemo Pharma Laboratories announced that the 83th Annual General Meeting(AGM) of the company will be held on 24 September 2025.Powered by Capital Market - Live
6 months agoCapital Market - Live
Corporate
Chemo Pharma Laboratories announces board meeting date
Chemo Pharma Laboratories will hold a meeting of the Board of Directors of the Company on 22 August 2025.Powered by Capital Market - Live
6 months agoCapital Market - Live
Earnings
Chemo Pharma Laboratories reports standalone net loss of Rs 11.81 crore in the June 2025 quarter
Net loss of Chemo Pharma Laboratories reported to Rs 11.81 crore in the quarter ended June 2025 as against net profit of Rs 0.25 crore during the previous quarter ended June 2024. There were no Sales reported in the quarter ended June 2025 and during the previous quarter ended June 2024.Powered by Capital Market - Live
6 months agoCapital Market - Live
Corporate
Chemo Pharma Laboratories to announce Quarterly Result
Chemo Pharma Laboratories will hold a meeting of the Board of Directors of the Company on 12 August 2025.Powered by Capital Market - Live
6 months agoCapital Market - Live
Corporate
Chemo Pharma Laboratories to convene board meeting
Chemo Pharma Laboratories will hold a meeting of the Board of Directors of the Company on 31 July 2025.Powered by Capital Market - Live
7 months agoCapital Market - Live
Earnings
Chemo Pharma Laboratories reports standalone net loss of Rs 0.34 crore in the March 2025 quarter
Net Loss of Chemo Pharma Laboratories reported to Rs 0.34 crore in the quarter ended March 2025 as against net loss of Rs 0.29 crore during the previous quarter ended March 2024. There were no Sales reported in the quarter ended March 2025 and during the previous quarter ended March 2024. For the full year,net profit declined 71.67% to Rs 0.34 crore in the year ended March 2025 as against Rs 1.20 crore during the previous year ended March 2024. There were no Sales reported in the year ended March 2025 and during the previous year ended March 2024.Powered by Capital Market - Live
8 months agoCapital Market - Live
Over the last 5 years, revenue has grown at a yearly rate of -9.12%, vs industry avg of 16.79%
Over the last 5 years, market share decreased from 0.02% to 0.01%
Over the last 5 years, net income has grown at a yearly rate of -4.71%, vs industry avg of 23.37%